marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Cassava Sciences Financial Ratios 2011-2024 | SAVA
Annual Financial Ratios Cassava Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-9.9 | -12.9 | -53.2 | -28.1 | -30.2 | -1.9 | -3.9 | -1.7 | -5.2 | -7.2 | 5.9 | -35.1 | -56.7 |
P/S |
- | - | - | - | - | - | - | - | - | - | 4.5 | 11.1 | 12.9 |
EPS |
-2.3 | -1.9 | -0.8 | - | -0.3 | -0.6 | -1.8 | -2.3 | -0.3 | -0.3 | 0.7 | -0.1 | -0.1 |
EV (Enterprise Value) |
858 M | 788 M | 1.5 B | 86.6 M | 118 M | -7.01 M | 37.6 M | 9.15 M | 45.4 M | 49.4 M | 139 M | 115 M | 130 M |
EBITDA per Share |
-2.5 | -1.97 | -0.83 | -0.25 | -0.281 | -0.617 | -1.82 | -2.29 | -2.17 | -1.92 | 4.88 | -0.59 | -0.531 |
EV/EBITDA |
-45.3 | -67.2 | -23.8 | 1.1 | -3.1 | -0.6 | -3.0 | -3.9 | 4.4 | -18.9 | -22.4 | ||
PEG |
-0.15 | -0.27 | -3.33 | 0.96 | -0.54 | -0.03 | -0.19 | 0.26 | 0.35 | 0.05 | 0.01 | 1.05 | -0.72 |
P/B |
7.0 | 4.3 | 6.8 | 1.9 | 6.3 | 0.6 | 4.8 | 1.3 | 2.5 | 2.2 | 3.8 | 9.2 | 3.3 |
P/CF |
-11.8 | -12.7 | -57.0 | -33.1 | -55.2 | -2.6 | -5.7 | -2.0 | -8.0 | -9.3 | -26.7 | -16.9 | -570.3 |
ROE % |
-70.72 | -33.51 | -12.75 | -6.87 | -20.96 | -33.41 | -122.81 | -79.68 | -48.17 | -30.92 | 65.31 | -26.23 | -5.89 |
ROA % |
-64.10 | -32.47 | -12.14 | -6.72 | -19.72 | -32.56 | -109.97 | -76.94 | -44.32 | -30.28 | 62.96 | -6.06 | -2.64 |
ROCE % |
-77.08 | -35.17 | -12.94 | -6.99 | -22.44 | -33.94 | -123.20 | -80.25 | -48.36 | -31.04 | 64.94 | -8.32 | -4.10 |
Current Ratio |
10.7 | 32.2 | 20.7 | 44.9 | 16.8 | 39.2 | 9.4 | 28.7 | 12.4 | 48.0 | 27.8 | 5.7 | 7.4 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Cassava Sciences
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.58 | 0.13 | - | -0.61 | -0.63 | - | - | -0.51 | -0.48 | - | - | -0.24 | -0.13 | -0.09 | - | -0.06 | -0.05 | -0.05 | - | -0.04 | -0.06 | -0.08 | - | -0.11 | -0.36 | -0.33 | - | -0.4 | -0.64 | -0.42 | -0.06 | -0.54 | -0.46 | -0.13 | -0.1 | -0.08 | -0.07 | -0.06 | -0.05 | -0.08 | -0.07 | -0.08 | 0.73 | -0.02 | -0.01 | -0.01 | -0.04 | -0.03 | - | - | -0.01 | -0.02 | -0.03 | - |
EBITDA per Share |
-0.63 | -1.32 | - | -0.66 | -0.68 | -0.63 | - | -0.53 | -0.49 | -0.44 | - | -0.24 | -0.13 | -0.09 | - | -0.06 | -0.05 | -0.05 | - | -0.04 | -0.07 | -0.08 | - | -0.1 | -0.35 | -0.32 | - | -0.39 | -0.63 | -0.42 | - | -0.54 | -0.46 | -0.13 | - | -0.08 | -0.07 | -0.06 | - | -0.08 | -0.07 | -0.08 | - | -0.02 | -0.01 | -0.01 | - | -0.03 | - | - | - | -20.1 | -30.2 | -0.01 |
ROE % |
-46.59 | -44.52 | -43.14 | -53.33 | -46.99 | -41.14 | -26.44 | -30.01 | -23.39 | -16.39 | -6.68 | -8.23 | -6.21 | -5.59 | -4.03 | -7.18 | -8.79 | -12.35 | -14.10 | -20.55 | -23.85 | -31.55 | -29.95 | -56.66 | -76.90 | -107.30 | -97.88 | -111.41 | -103.58 | -76.87 | -79.68 | -81.53 | -75.15 | -70.46 | -48.17 | -38.17 | -34.49 | -31.10 | -30.92 | -27.12 | -19.87 | -12.39 | -3.05 | -14.85 | -25.07 | -25.43 | -12.56 | -14.40 | -4.43 | -6.15 | -5.01 | -1.84 | -2.70 | -0.47 |
ROA % |
-39.70 | -40.58 | -39.37 | -49.14 | -44.04 | -37.85 | -24.13 | -27.61 | -14.15 | -15.97 | -6.55 | -8.07 | -6.10 | -5.48 | -3.94 | -6.91 | -8.36 | -11.66 | -13.26 | -19.55 | -22.88 | -30.54 | -29.19 | -53.10 | -70.73 | -96.96 | -87.65 | -100.71 | -95.03 | -72.24 | -76.94 | -78.02 | -71.30 | -66.25 | -44.32 | -35.44 | -32.57 | -29.94 | -30.28 | -26.53 | -19.41 | -12.08 | -2.94 | -5.66 | -6.87 | -6.50 | -2.90 | -3.73 | -1.82 | -2.81 | -2.25 | -0.82 | -1.21 | -0.21 |
ROCE % |
-86.82 | -84.48 | -47.01 | -57.76 | -50.52 | -43.60 | -27.38 | -31.02 | -23.93 | -16.66 | -6.76 | -8.32 | -6.23 | -5.63 | -4.15 | -7.67 | -9.64 | -13.59 | -15.31 | -21.85 | -24.87 | -32.19 | -30.12 | -56.89 | -77.11 | -107.52 | -98.22 | -117.22 | -109.45 | -82.83 | -66.61 | -79.16 | -72.71 | -67.91 | -32.92 | -41.77 | -38.07 | -34.67 | -25.63 | -27.24 | -19.99 | -12.52 | -3.18 | -15.78 | -26.78 | -28.04 | -15.65 | -17.96 | -7.66 | -8.95 | -6.60 | -2.30 | -3.22 | -1.08 |
Current Ratio |
3.9 | - | 10.7 | 9.9 | 11.0 | 15.5 | 32.2 | 24.2 | - | 34.4 | 20.7 | 41.0 | 58.3 | 99.2 | 44.9 | 44.9 | 44.9 | 44.9 | 16.9 | 16.9 | 16.9 | 16.9 | 39.4 | 39.4 | 39.4 | 39.4 | 9.6 | 9.6 | 9.6 | 9.6 | 29.0 | 29.0 | 29.0 | 29.0 | 12.5 | 12.5 | 12.5 | 12.5 | 48.1 | 48.1 | 48.1 | 48.1 | 27.8 | 27.8 | 27.8 | 27.8 | 1.3 | 1.3 | 1.3 | 1.3 | 1.8 | 1.8 | 1.8 | 1.8 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.8 | 18.9 | 15.1 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.8 | 18.9 | 15.1 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.8 | 18.9 | 15.1 | - |
All numbers in USD currency